This post was just published on ZYX Buy Change Alert.
BPMC is a biotech firm focused on developing cancer treatment therapies. This is a new IPO. It is a high risk high reward situation suitable only for aggressive investors as the risk of loss is high.
Here is the plan:
Consider buying a 5% tranche in the zone of $22.00 to $23.50. It is trading at $23 as of this writing. Consider buying a 10% tranche in the zone of $21.00 to $21.67; another 10% tranche in the zone of $20 to $20.37. 10% in the zone of $19.00 to $19.31 and 20% at $18.00 to $18.57.
Very long-term target zone is $85 to $100.
Here is the plan on stop zones. 15% in the zone of $17.73 to $17.88. 15% in the zone of $16.73 to $16.88. Mental stop on the remaining 25% under $15.73.
You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.